Lipid-lowering efficacy and safety of alirocumab in patients with or without diabetes: A sub-analysis of ODYSSEY COMBO II

  1. Leiter, L.A.
  2. Zamorano, J.L.
  3. Bujas-Bobanovic, M.
  4. Louie, M.J.
  5. Lecorps, G.
  6. Cannon, C.P.
  7. Handelsman, Y.
Aldizkaria:
Diabetes, Obesity and Metabolism

ISSN: 1463-1326,  1462-8902

Argitalpen urtea: 2017

Alea: 19

Zenbakia: 7

Orrialdeak: 989-996

Mota: Artikulua

DOI: 10.1111/DOM.12909 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus